諾華藥廠
(NVS)

  • 股價
    102.72
  • 漲跌
    2.53
  • 漲幅
    2.53%
  • 成交量
    9.9萬
YahooFinanceBusiness
Tuesday, Biogen Inc (NASDAQ:BIIB) posted fourth-quarter 2023 sales of $2.39 billion, missing the consensus of $2.46 billion, down 6% Y/Y and 5% at constant currency (CC).
Adjusted EPS of $2.95, down 27%, missing the consensus of $3.18.
Biogen’s partner, Eisai Co Ltd (OTC:ESALY), has faced a delay
    YahooFinanceBusiness
    In this article, we will look into the 30 countries with highest standard of living ranked by GDP (PPP) per capita. If you want to skip our detailed analysis you can go directly to the 10 Countries with Highest Standard of Living Ranked by GDP (PPP) Per Capita. 
    For a country to become a place of 
      YahooFinanceBusiness
      Genmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple sclerosis, thyroid eye disease and various autoimmune diseases.
      Genmab has an extensive portfolio of both Food and Drug Administration-approved and 
        YahooFinanceBusiness
        Finding stocks that trade at low valuations is fairly easy as there are many companies with weak prospects trading at low valuations. However, many of those companies are cheap for a reason and lack a catalyst to drive a valuation re-rating.
        Pfizer Inc. (NYSE:PFE) is a cheap stock based on most co
          YahooFinanceBusiness
          (Bloomberg) -- Drug developers are capitalizing on the industry’s momentum by tapping public investors for the first time, as corporate takeovers and a welcoming market lift optimism about biotechnology.
          Most Read from Bloomberg
          Haley Loses Nevada Primary to ‘None of These Candidates’ Option
          Chi